Streetbeat News

Price Targets

PTEN

Citigroup analyst Scott Gruber maintains a Neutral rating on Patterson-UTI Energy (NASDAQ:PTEN) and raises the price target from $12 to $13.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 4:21 pm

HEXO

Canaccord Genuity analyst Matt Bottomley maintains a Hold rating on HEXO (NASDAQ:HEXO) and lowers the price target from C$1.5 to C$1.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 4:13 pm

HAIVF

Canaccord Genuity analyst Robert Young maintains a Buy rating on Haivision Systems (OTC:HAIVF) and lowers the price target from C$5 to C$4.75.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 4:12 pm

CP

CIBC analyst Kevin Chiang maintains an Outperformer rating on Canadian Pacific Kansas (NYSE:CP) but lowers the price target from $125 to $123.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 4:08 pm

ACB

CIBC analyst John Zamparo maintains a Neutral rating on Aurora Cannabis (NASDAQ:ACB) and lowers the price target from C$1.75 to C$1.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 4:04 pm

TFII

In the last 3 months, 7 analysts have offered 12-month price targets for TFI International (NYSE:TFII), with an average price target of $132.0, a decrease of 0.51% from the previous average price target of $132.67.

Portfolio Pulse from Benzinga Insights

June 16, 2023 | 4:02 pm

AGFMF

CIBC analyst Nik Priebe maintains a Neutral rating on AGF Management (OTC:AGFMF) and lowers the price target from C$9 to C$8.5.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 4:01 pm

FWRD

In the last 3 months, 4 analysts have offered 12-month price targets for Forward Air (NASDAQ:FWRD), with an average price target of $125.5, up 0.94% from the previous average of $124.33. The company has received 1 bullish and 3 somewhat bullish ratings.

Portfolio Pulse from Benzinga Insights

June 16, 2023 | 4:00 pm

TARS

Guggenheim analyst Eddie Hickman maintains a Buy rating on Tarsus Pharmaceuticals (NASDAQ:TARS) and raises the price target from $40 to $42.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 3:59 pm

TOI

Guggenheim analyst Sandy Draper maintains a Buy rating on Oncology Institute (NASDAQ:TOI) but lowers the price target from $3 to $2.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 3:58 pm